Health TrialsbyHealthPanel

Effect of Some Drugs on Rheumatoid Arithritis Activity

ConditionRheumatoid Arthritis
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorSherief Abd-Elsalam

About this trial

Effect of Some Drugs on Rheumatoid Arithritis Activity.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Rheumatoid arthritis

Disqualifiers

liver or renal disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • Rupatadine

    Drug

    Rupatadine 10 mg daily

  • Montelukast

    Drug

    Montelukast 10 mg daily

Treatment groups

75 Participants
are divided into 3 treatment groups
Group A: No interventionNo intervention 0 interventions
Group B: RupatadineActive comparator 1 intervention
Group C: MontelukastActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

se level of IL-17

change in level of IL-17

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov
Apply now